Intravenous Glutamine Administration Improves Glucose Tolerance and Attenuates the Inflammatory Response in Diet-Induced Obese Mice after Sleeve Gastrectomy

Obesity is a health problem associated with many metabolic disorders. Weight reduction can effectively alleviate obesity-associated complications. Sleeve gastrectomy is a commonly used bariatric surgery and is considered safe and effective for improving outcomes. Glutamine (GLN) is an amino acid with anti-oxidative and anti-inflammatory properties. This study used a mouse model of sleeve gastrectomy to investigate the impacts of intravenous GLN administration on glucose tolerance and adipocyte inflammation short-term after surgery. C57BL6 male mice were divided into normal control (NC) and high-fat diet groups. The high-fat diet provided 60% of energy from fat for 10 weeks to induce obesity. Mice fed the high-fat diet were then assigned to a sham (SH) or sleeve gastrectomy with saline (S) or GLN (G) groups. The S group was intravenously injected with saline, while the G group was administered GLN (0.75 g/kg body weight) via a tail vein postoperatively. Mice in the experimental groups were sacrificed on day 1 or 3 after the surgery. Results showed that obesity resulted in fat accumulation, elevated glucose levels, and adipokines production. Sleeve gastrectomy aggravated expressions of inflammatory cytokine and macrophage infiltration markers, cluster of differentiation 68 (CD68), epidermal growth factor-like module-containing mucin-like hormone receptor-like 1 (EMR-1), and macrophage chemoattractant protein-1, in adipose tissues. Treatment of obese mice with GLN downregulated hepatic proteomic profiles associated with the gluconeogenesis pathway and improved glucose tolerance. Moreover, macrophage infiltration and adipose tissue inflammation were attenuated after the sleeve gastrectomy. These findings imply that postoperative intravenous GLN administration may improve glucose tolerance and attenuate inflammation shortly after the bariatric surgery in subjects with obesity.

[1]  A. Courcoulas,et al.  Benefits and Risks of Bariatric Surgery in Adults: A Review. , 2020, JAMA.

[2]  Te-Wei Ho,et al.  Parenteral glutamine supplementation improves serum albumin values in surgical cancer patients. , 2020, Clinical nutrition.

[3]  M. McCarthy,et al.  Glutamine Links Obesity to Inflammation in Human White Adipose Tissue. , 2019, Cell metabolism.

[4]  Ming-Tsan Lin,et al.  Antecedent Administration of Glutamine Benefits the Homeostasis of CD4+ T Cells and Attenuates Lung Injury in Mice With Gut-Derived Polymicrobial Sepsis. , 2019, JPEN. Journal of parenteral and enteral nutrition.

[5]  Ming-Tsan Lin,et al.  Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia. , 2019, Nutrition Research.

[6]  G. Z. Rocha,et al.  Oral Glutamine Supplementation Reduces Obesity, Pro-Inflammatory Markers, and Improves Insulin Sensitivity in DIO Wistar Rats and Reduces Waist Circumference in Overweight and Obese Humans , 2019, Nutrients.

[7]  M. Kratz,et al.  Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. , 2018, Comprehensive Physiology.

[8]  A. Shabbir,et al.  Is Laparoscopic Sleeve Gastrectomy for Asian Super Obese a Safe and Effective Procedure? , 2018, Annals of the Academy of Medicine, Singapore.

[9]  A. La Cava.  Leptin in inflammation and autoimmunity , 2017, Cytokine.

[10]  S. Yeh,et al.  Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD‐1/PD‐L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis , 2017, JPEN. Journal of parenteral and enteral nutrition.

[11]  Hsing-Yi Chang,et al.  Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors , 2017, PloS one.

[12]  G. Angelini,et al.  Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. , 2015, Pharmacology & therapeutics.

[13]  D. Heyland,et al.  Parenteral glutamine supplementation in critical illness: a systematic review , 2014, Critical Care.

[14]  J. Gugenheim,et al.  Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots , 2014, Surgical Endoscopy.

[15]  W. Garvey,et al.  A complications-based clinical staging of obesity to guide treatment modality and intensity , 2013, Current opinion in endocrinology, diabetes, and obesity.

[16]  Joanne M. Smith,et al.  Health Evaluation of Experimental Laboratory Mice , 2012, Current protocols in mouse biology.

[17]  W. Chiu,et al.  Effects of glutamine supplementation on oxidative stress-related gene expression and antioxidant properties in rats with streptozotocin-induced type 2 diabetes , 2011, British Journal of Nutrition.

[18]  Jaw-Town Lin,et al.  Health-related Quality of Life in Adult Patients with Morbid Obesity Coming for Bariatric Surgery , 2008, Obesity surgery.

[19]  T. Harris,et al.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[20]  T. Wadden,et al.  The Evolution of Very‐Low‐Calorie Diets: An Update and Meta‐analysis , 2006, Obesity.

[21]  J. Kulig,et al.  The Clinical Value of Parenteral Immunonutrition in Surgical Patients , 2005, Acta chirurgica Belgica.

[22]  Stephan Rössner,et al.  Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. , 2004, Circulation.

[23]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[24]  G. Hotamisligil,et al.  Inflammatory pathways and insulin action , 2003, International Journal of Obesity.

[25]  S. Ishibashi,et al.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.

[26]  B. Wolfe,et al.  Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass. , 2003, American journal of surgery.

[27]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  R. Strieter,et al.  Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. , 1999, Journal of immunology.

[30]  A. Orekhov,et al.  CD68/macrosialin: not just a histochemical marker , 2017, Laboratory Investigation.

[31]  D. Eisenberg,et al.  Sleeve Gastrectomy as a Stand-alone Bariatric Operation for Severe, Morbid, and Super Obesity , 2013, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[32]  N. Abumrad,et al.  Mouse Models of Bariatric Surgery. , 2012, Current protocols in mouse biology.

[33]  S. Gordon,et al.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage , 1981, European journal of immunology.